Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use

Gopalakrishnan C, Gagne JJ, Sarpatwari A, Dejene SZ, Dutcher SK, Levin R, Franklin JM, Schneeweiss SG, Desai RJ - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
  • Regulation and Clinical Evidence

Summary:

This methodologic study evaluated how different socioeconomic status (SES) indicators affect confounding adjustment in observational medication studies, finding that claims-based variables alone substantially improved balance on SES measures. While adding SES data further improved balance, it did not materially change outcome estimates for cardiovascular events or emergency department visits in a cohort of 7,109 Medicare patients initiating atorvastatin. The results suggest that claims-based proxies may be sufficient for mitigating SES confounding when aggregate-level SES information is unavailable in observational studies.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access